Expression study of androgen, estrogen and progesterone receptors by immunohistochemistry in patients with frontal fibrosing alopecia

Simple item page
dc.contributor.authorCarreno-Orellana, Nestor
dc.contributor.authorAlfaro-Sepulveda, Daniela
dc.contributor.authorTraipe, Maria Paz
dc.contributor.authorVial-Letelier, Veronica
dc.date.accessioned2025-01-20T20:10:06Z
dc.date.available2025-01-20T20:10:06Z
dc.date.issued2023
dc.description.abstractIntroduction: Frontal fibrosing alopecia (FFA) is a lymphocytic primary cicatricial alopecia, which etiology is unknown. Multiple pharmacological therapies have been developed, being finasteride alone or in combination with corticosteroids an effective treatment. Objectives: To evaluate if the expression of androgen, progesterone and estrogen receptors in the hair follicle of patients with FFA differs from healthy controls.Methods: Microarrays were constructed from scalp biopsies taken from patients with a clinical diagnosis of FFA, and histopathological diagnosis of FFA/lichen planopilaris; and from healthy scalp samples from patients with similar demographic characteristics to those of the case group. Immunohistochemical staining was performed to determine the expression of androgen, estrogen and progesterone receptors in all samples.Results: This study included 27 patients with clinical and biopsy-proven FFA and 26 controls. 48% of scalp samples from patients with FFA presented androgen receptors, in contrast to 27% of samples from patients without FFA, although this difference was not statistically significant (p value >0.05). Estrogen and progesterone receptors were negative in all samples.Discussion: There is a tendency for patients with FFA to have a higher concentration of androgen receptors than healthy patients. Studies with prospective designs and larger sample sizes are required to validate these results, which could also evaluate the correlation between the presence of androgen receptors and the response to antiandrogen treatment.
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.rmclc.2023.02.006
dc.identifier.eissn0716-8640
dc.identifier.urihttps://doi.org/10.1016/j.rmclc.2023.02.006
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/92043
dc.identifier.wosidWOS:001009507300001
dc.issue.numero2
dc.language.isoen
dc.pagina.final154
dc.pagina.inicio149
dc.revistaRevista medica clinica las condes
dc.rightsacceso restringido
dc.subjectKey Alopecia
dc.subjectAlopecia Cicatrisata
dc.subjectLichen Planopilaris
dc.subjectAndrogens
dc.subject5-alpha Reductase Inhibitors
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleExpression study of androgen, estrogen and progesterone receptors by immunohistochemistry in patients with frontal fibrosing alopecia
dc.typeartículo
dc.volumen34
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas